CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
CHA Urges Senators to Oppose Reconciliation Bill that Hurts Children’s Care
CHA Response to Agencies’ Request for Information on Regulatory Reform
CHA's Response to The MAHA Commission's Make Our Children Healthy Again: Assessment
CHA Urges Senators to Oppose Reconciliation Bill that Hurts Children’s Care
The latest bill language includes significant cuts to Medicaid which threaten access to care for all American children
June 28, 2025
CHA Response to Agencies’ Request for Information on Regulatory Reform
Children’s Hospital Association recommended regulatory reforms to strengthen the ability to provide age-appropriate, timely, and high-quality care to children across the nation.
June 25, 2025
CHA's Response to The MAHA Commission's Make Our Children Healthy Again: Assessment
The Children's Hospital Association encourages HHS to support, engage with, and build upon children’s hospitals’ child health improvement initiatives taking place across the country.
June 24, 2025
